Clinical Trials for PIK3CA-Related Overgrowth Spectrum (PROS)

Find clinical trials for pik3ca-related overgrowth spectrum (pros). Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

NCT ID: NCT06789913

This clinical trial is studying a new medication called RLY-2608, which is designed to help people with a condition called PIK3CA-Related Overgrowth Spectrum (PROS) and other related malformations ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cincinnati, Ohio, United States, St. Louis, Missouri, United States +2 more

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)

NCT ID: NCT06975618

This clinical trial is testing a new medication called CYH33 for patients with certain conditions known as PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Beijing, Beijing, China +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions